Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dynamin 1 pseudogene 34 (DNM1P34) is annotated in the human genome as a pseudogene related to the functional DNM1 gene, which encodes the large GTPase dynamin-1 involved in membrane fission and endocytosis. DNM1P34 itself is not known to be transcribed into a protein or to exert any biological or disease-related function. It is not considered a therapeutic target, nor is it involved in any known disease pathways[6]. Summary: DNM1P34 is a pseudogene, not a protein, receptor, or functional therapeutic target. It should not be used to represent any active molecular mechanism or drug target in biomedical research or pharmacology[6]. If you are looking for the functional protein involved in endocytosis and GTPase activity, refer to Dynamin-1 (encoded by the DNM1 gene)[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynamin 1 pseudogene 34 (DNM1P34).